Latest News and Press Releases
Want to stay updated on the latest news?
-
Block & Leviton announces a securities fraud lawsuit has been filed against ADMA Biologics. Investors should contact Block & Leviton by 8/10/2026.
-
Block & Leviton is investigating ADMA Biologics, Inc. (Nasdaq: ADMA) for potential securities fraud. Investors should contact the firm to recover losses.